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better medical and surgical care [2]. The pregnant 
woman with heart disease represents a unique challenge 
to the obstetrician and the obstetric anesthesiologist. 
Determination of the appropriate anesthetic modalities 
requires an understanding of the parturient’s patho-
physiology, as well as an understanding of pharmaco-
logical therapy and the potential for their interaction 
with peripartum anesthetic care.
Over the past 25 years, greater awareness of the phys-
iological burden that pregnancy places on an already 
compromised cardiovascular system in this subset of 
pregnant women has led to better counseling before 
conception, and to major advances in treatment. For-
merly, rheumatic heart disease was the most common 
cardiac disorder in pregnancy, with mitral stenosis the 
single most prevalent resulting lesion. Today, in gen-
eral, the incidence of rheumatic heart disease has de-
creased dramatically in the United States and Western 
Europe, but in many other regions of the world it still 
remains an important cause of maternal morbidity and 
mortality [1,3–5].
The goal of this article is to review the current recom-
mendations for the management of labor pain in women 
with valvular heart disease.
Cardiovascular changes during pregnancy
Anesthesiologists providing care to pregnant women 
should remember that pregnancy maximally dilates the 
uterine vasculature; so that autoregulation is absent, 
and uterine blood fl ow is entirely dependent on mater-
nal mean arterial blood pressure (MAP). The compen-
satory cardiovascular changes during pregnancy may 
complicate the evaluation of intravascular blood vol-
ume and the assessment of peripartum blood loss [6]. 
Maternal hemodynamic measurements may not always 
accurately refl ect the status of the uteroplacental circu-
lation. Pregnancy represents a state of accelerated but 
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Introduction
Pregnancy results in dramatic changes in the cardiovas-
cular system. Maternal heart disease complicates 0.2%–
3% of pregnancies [1]. The incidence of heart disease 
during pregnancy is steadily declining as a result of 
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compensated intravascular coagulation, which has both 
advantages and disadvantages for the parturient [7]. 
Increased levels of coagulation factors may improve 
hemostasis following obstetric bleeding; however, at the 
same time, parturients remain at increased risk for 
thromboembolic complications during periods of im-
mobilization. Because buffering capacity during preg-
nancy is diminished, pregnant women rapidly develop 
metabolic acidosis during periods or hypoperfusion and 
hypoxia [1].
Four principal changes in the cardiovascular system 
during pregnancy that present unique problems to the 
parturient with underlying heart disease have been well 
delineated [1,8] and pose special anesthetic implica-
tions. First, there is a 50% increase in intravascular 
volume that generally peaks by the early-to-middle 
third trimester. Second, there is a progressive decrease 
in systemic vascular resistance (SVR) throughout preg-
nancy, so that MAP is preserved at normal values, 
despite a 30%–40% increase in cardiac output (CO). 
Systolic blood pressure (SBP) is normally decreased 
[6–8]. Third, the compromised cardiovascular system is 
further stressed by the marked fl uctuations in CO ob-
served during labor. Pain and apprehension may pre-
cipitate an increase in CO to as much as 40%–50% over 
those levels seen in the late second stage of labor [6]. 
Further, each uterine contraction serves, in effect, as an 
autotransfusion to the central blood volume, resulting 
in an increase in CO of 10%–25% [1]. The fourth 
consideration is the hypercoagulability associated with 
pregnancy and the possible need for appropriate anti-
coagulation, especially in those patients at increased 
risk for arterial thrombosis and embolization (pros-
thetic heart valve) [9–11].
Assessment of the parturient with heart disease
Antepartum and peripartum care of pregnant women 
with heart disease should include a joint obstetric, cardi-
ological, and anesthetic evaluation of each parturient 
[12]. Optimal obstetric and anesthetic management 
requires a thorough assessment of the anatomic and 
functional capacity of the diseased heart, along with 
an analysis of how the described major physiological 
changes are likely to affect the specifi c limitations 
imposed by the intrinsic disease [1,6]. Specifi cally, to de-
termine the most appropriate anesthetic regimen, the 
obstetric anesthesiologist must consider the following; 
fi rst, the patient’s tolerance to pain during labor, deliv-
ery, and/or surgery; second, the impact of uterine 
contraction–induced autotransfusion; third, the postpar-
tum changes induced by the relief of vena cava obstruc-
tion; fourth, the potential for postpartum hemorrhage; 
and fi fth, the use of uterine oxytocic agents.
The basic principles of obstetric anesthesia manage-
ment must always apply [13–15]; fi rst, provisions for the 
maintenance of uteroplacental perfusion by the avoid-
ance of aortocaval compression; second, minimizing 
sympathetic blockade coupled with intravascular vol-
ume maintenance; third, monitoring of the parturient 
and the fetus; and fourth, provision for aspiration 
prophylaxis.
Peripartum considerations
Labor analgesia during the fi rst stage of labor is 
focused on reducing the pain-related increases in cate-
cholamine levels and avoiding aortocaval compression. 
Intravenous fl uid management should be carefully mon-
itored to avoid both a lack of and an excess of fl uids [1]. 
Arterial, central venous, and/or pulmonary artery 
monitoring may be required to optimally manage the 
patient. However, such lines are generally reserved 
for symptomatic women and patients who have severe 
(narrowing to less than 1 cm2) aortic stenosis or other 
hemodynamically signifi cant valvular lesions.
Appropriate labor analgesia should be provided. 
Continuous lumbar epidural analgesia with local anes-
thetics, opioids, or both, is frequently optimal. Limited 
sympathetic blockade may prove helpful with mitral 
valve lesions because of the effect on both preload and 
afterload [1,6]. For a patient whose condition is so com-
promised that even the modest changes induced by 
segmental epidural analgesia are worrisome, the use of 
subarachnoid opioid analgesia by single injection or 
continuous catheter may be benefi cial because the 
hemodynamic alterations of sympathetic blockade are 
avoided.
Once the patient with signifi cant cardiac disease has 
entered the second stage of labor, it is prudent for her 
to avoid pushing (to avoid increase in CO). The lithot-
omy position may need to be avoided for patients with 
lesions such as mitral stenosis, inasmuch as this position 
results in an acute increase in central blood volume 
[1,6,16].
For second-stage management, analgesia for uterine 
contractions and anesthesia of the perineum are the 
objectives. Uterine contractions spontaneously bring 
the infant’s head to a deliverable position, and delivery 
may then be assisted by the application of a vacuum 
extractor or forceps. Again, a regional technique is op-
timal. Epidural analgesia or anesthesia may be con-
tinued. If an epidural block is not used, a low spinal 
anesthetic may be appropriate. Pudendal nerve block, 
while not providing as complete analgesia as an epidu-
ral, may be employed as an adjunct to regional anes-
thesia, or used alone.
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It is generally thought that cesarean section should 
be reserved for obstetric indications only, and that 
the presence of heart disease should not infl uence that 
decision. The choice of anesthesia depends on the lesion 
and its severity. Although spinal anesthesia may be 
appropriate for some patients with well-compensated 
lesions, adequate intravascular volume management 
to maintain maternal preload, SVR, and hemoglobin-
oxygen saturation is necessary. Epidural anesthesia pro-
vides the least amount of alteration in hemodynamics 
during cesarean section, although general anesthesia 
can be equally safe when the abrupt changes associated 
with laryngoscopy and intubation, as well as suction 
and extubation, are blunted by the appropriate choice 
of pharmacological agents and anesthetic technique 
[1,6,17].
Valvular heart disease: general considerations
The presence of valvular heart disease due to either ac-
quired or congenital etiology in a pregnant woman 
poses a clinical challenge to physicians involved in her 
antepartum and peripartum care [1,6,18–24]. Rheumatic 
fever continues to be the predominant etiology of val-
vular heart disease in pregnancy [1,15,18,20,22]. Com-
plications during pregnancy include atrial dysrhythmias, 
univentricular or biventricular failure, systemic or pul-
monary embolism, and infective endocarditis, with an 
overall incidence of complications estimated at 15% of 
all patients with valvular disease [1].
In general, regurgitant lesions are well tolerated dur-
ing pregnancy because the increased plasma volume 
and lowered systemic vascular resistance result in 
increased CO [1,6,20]. In contrast; stenotic valvular 
disease is poorly tolerated with advancing pregnancy, 
owing to the inability to increase CO in relation to the 
increased plasma volume preload [1,6,20].
Specifi c valvular lesions
Mitral stenosis
Mitral stenosis accounts for nearly 90% of rheumatic 
heart lesions in pregnancy, with 25% of patients fi rst 
experiencing symptoms during pregnancy [1,6,15]. 
Mitral stenosis may occur as an isolated lesion or in 
conjunction with other valvular disease. The principal 
pathophysiological derangement is a decrease in the 
area of the mitral valve, resulting in obstruction to left 
ventricular fi lling. This hemodynamic aberration leads 
to a relatively fi xed CO. Although initially the left atri-
um may overcome this obstruction, with progression of 
the disease left atrial volume and pressure increase and 
lead to a progressive increase in pulmonary capillary 
wedge pressure and pulmonary venous pressure; pul-
monary hypertension and right ventricular hypertrophy 
and failure may then occur [1,6,21–28]. Fetal mortality 
rates increase with deteriorating maternal condition 
and reach 25% in pregnant women with severe mitral 
stenosis.
Peripartum anesthetic management is oriented to-
ward the avoidance of tachycardia, as the time required 
for left ventricular diastolic fi lling is prolonged in mitral 
stenosis. Patients who are asymptomatic at term gener-
ally require increased vigilance, but should not require 
invasive monitoring. Patients with marked symptoms 
are at signifi cant risk in the peripartum period and 
should receive peripheral and pulmonary artery cathe-
ter monitoring continuing through a minimum of 24 h 
postpartum [1,6,15]. An increase in central circulating 
blood volume may occur suddenly in the immediate 
postpartum period, and tolerance of this intravascular 
load may be poor, especially by patients with a fi xed CO 
[1,6,15].
Vaginal delivery is best accomplished with segmental 
lumbar epidural analgesia to minimize hemodynamic 
changes. Combined spinal-epidural analgesia (CSEA) 
is an attractive alternative to the conventional epidural 
block. A sudden decrease in SVR may be tolerated 
poorly following the development of refl ex tachycardia 
[1,6,15]. The addition of opioids to the dilute local an-
esthetic mixture enhances the quality of labor analgesia, 
yet does not add to the sympathetic blockade. Opioids 
alone may be administered by the epidural or subara-
chnoid route for the critically ill patient. Adequate 
segmental and perineal anesthesia reduces catechol-
amine-induced increases in heart rate as well as the urge 
to push, allowing fetal descent to be accomplished by 
uterine contractions and avoiding the deleterious effects 
of the Valsalva maneuver during the second stage of 
labor [1,6,15]. When epidural anesthesia has not been 
used, a low spinal anesthetic may be administered to 
allow for a controlled second stage and delivery. Puden-
dal nerve block can provide adequate pain relief for 
some patients, and it may be suitable in selected situa-
tions where neuraxial anesthesia is contraindicated.
Cesarean section should be considered for obstetric 
indications. Anesthetic options for cesarean delivery 
must take into account the additional potential hazards 
of marked fl uid shifts secondary to anesthetic technique, 
operative blood loss, and the mobilization of fl uid in 
the postpartum period. Epidural anesthesia is preferred 
over spinal anesthesia because the former results in 
slower onset of blockade and, thus, more controllable 
hemodynamic alterations [1,6,15]. Prophylactic ad-
ministration of ephedrine and arbitrary intravascular 
volume loading are best avoided; instead, a careful titra-
tion of anesthetic level allows judicious and appropriate 
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intravenous fl uid administration, which should be 
guided by hemodynamic monitoring in the symptomatic 
patient. These patients may be prone to develop hypo-
tension with epidural anesthesia secondary to a combi-
nation of venous pooling and prior beta-adrenergic 
blockade and diuretic therapy [1,15]. The usual vaso-
pressor choice of ephedrine should be avoided, as it may 
result in tachycardia. Instead, judicious use of low-dose 
phenylephrine assists in restoration of the mother’s 
blood pressure with little or no unwanted effect on 
uteroplacental perfusion.
Some patients with mitral stenosis may require gen-
eral anesthesia. General anesthesia may also provide 
a very stable hemodynamic course if the sympathetic 
stimulation associated with laryngoscopy and intuba-
tion as well as with suction and extubation is minimized. 
This may be accomplished with anesthetic agents and/or 
beta-adrenergic blockade. Induction of general anesthe-
sia should be carefully accomplished without drugs that 
commonly produce tachycardia [1,6,15]. Anesthesia is 
maintained with opioids, neuromuscular blocking drugs, 
nitrous oxide, and oxygen. Emergence must be carefully 
controlled to ensure avoidance of tachycardia.
Aortic stenosis
Congenital aortic defects are the usual causes of aortic 
stenosis in women of reproductive age [18]. Rheumatic 
disease-related aortic stenosis rarely complicates preg-
nancy, primarily because the natural history of this le-
sion occurring secondary to rheumatic heart disease 
typically requires three to four decades to achieve 
severity adequate to produce symptoms [1,15,18]. The 
pathophysiology of severe aortic stenosis entails nar-
rowing of the valve area to less than 1 cm2, associated 
with a transvalvular gradient of 50 mmHg, resulting in 
signifi cant increases in valvular afterload to left ven-
tricular ejection [18]. The left ventricle appropriately 
and concentrically hypertrophies and becomes mark-
edly less compliant, although contractility is usually well 
preserved. The transvalvular gradient increases pro-
gressively throughout pregnancy as a result of increas-
ing blood volume and decreasing SVR [29–31].
Peripartum anesthetic management encompasses the 
following goals: (1) avoiding both tachycardia and bra-
dycardia; (2) maintaining adequate preload in order 
that the left ventricle may generate an adequate CO 
across the stenotic valve; and (3) maintaining hemody-
namic parameters within a narrow therapeutic win-
dow. Patients with transvalvular gradients greater than 
50 mmHg and patients with symptomatic aortic stenosis 
warrant invasive monitoring with peripheral and pulmo-
nary artery catheters [1,6,15].
Labor analgesia with segmental epidural anesthesia 
or CSEA remains a controversial issue, because these 
patients may not be able to tolerate the decreases in 
preload and afterload due to sympathetic blockade 
[1,15,16]. Kuczkowski and Chow [16] described a case 
of a parturient with severe aortic stenosis who received 
uneventful CSEA with levobupivacaine and fentanyl 
for the fi rst stage of labor; however, in the second stage 
of labor, cesarean section under general anesthesia was 
required for fetal indications (fetal distress). The au-
thors concluded that the anesthetic management of a 
parturient with aortic stenosis must be based on indi-
vidual assessment of cardiac function and reserve, and 
anticipation of the impact of the selected anesthetic 
technique (regional or general for vaginal or abdominal 
delivery) on cardiac performance [16].
Subarachnoid or epidural opioids, whether alone or 
in combination with an epidural segmental anesthetic, 
are other appropriate choices. Spinal opioids have no 
cardiovascular effects; myocardial contractility is unal-
tered, preload is preserved, and, most importantly, SVR 
is not diminished by this technique [1,15,16]. For cesar-
ean section, either judiciously titrated epidural anesthe-
sia or general anesthesia may be utilized. General 
anesthesia should be accomplished with the same cau-
tion that applies for parturients with mitral stenosis; 
myocardial depression associated with volatile anes-
thetics should be avoided [1,15,16].
Mitral regurgitation
Mitral regurgitation is the second most prevalent valvu-
lar lesion in pregnancy [1]. In young women, mitral 
regurgitation is most commonly due to mitral valve pro-
lapse [18]. Chronic left ventricular volume overload and 
workload are usually well tolerated, with symptoms de-
veloping relatively late in life after childbearing age; 
thus, most patients with mitral regurgitation tolerate 
pregnancy well [15]. Complications include an increased 
risk of atrial fi brillation, bacterial endocarditis requiring 
antibiotic prophylaxis, systemic embolization, and pul-
monary congestion during pregnancy. Congenital mitral 
valve prolapse is much more common among pregnant 
women than mitral regurgitation, and may be present in 
10%–15% of pregnancies. It is a well-tolerated and gen-
erally benign form of mitral regurgitation [1,16].
The pathophysiology of regurgitation through an in-
competent mitral valve results in chronic volume over-
load and dilatation of the left ventricle. If left ventricular 
compromise is suffi ciently longstanding and severe, the 
increase in plasma volume with pregnancy progression 
may result in pulmonary venous congestion. By con-
trast, the decreasing SVR associated with pregnancy 
may serve to improve forward fl ow across the aortic 
valve at the expense of regurgitant fl ow. Increases in 
SVR that occur with labor pain, uterine contractions, or 
surgical stimulation may result in an increase in the 
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proportion of regurgitant blood fl ow, perhaps leading to 
acute left ventricular failure [1,15].
Provision of adequate labor analgesia should mini-
mize the peripheral vasoconstriction and thus attenuate 
the increase in left ventricular afterload associated with 
labor pain. Sympathetic blockade also serves to de-
crease SVR and is benefi cial in this regard; the caveat 
here is that venous capacitance will increase, and one 
must be prepared to augment preload cautiously to 
maintain left ventricular fi lling volume [15]. Asymptom-
atic patients at term are unlikely to require invasive 
monitoring. In symptomatic patients, invasive monitor-
ing should be utilized.
Aortic regurgitation
In young women, aortic regurgitation may be congenital 
or acquired. If congenital, it is commonly associated 
with other lesions; if acquired, it may be secondary to 
rheumatic heart disease or endocarditis in association 
with aortic root dissection [1,6,15,18]. Symptoms follow-
ing rheumatic fever usually develop during the fourth 
or fi fth decade of life; thus, most women in whom this 
is the dominant lesion have uneventful pregnancies.
The basic pathophysiology is of chronic volume over-
loading of the left ventricle resulting in hypertrophy and 
dilation associated with increased compliance. Because 
of hypertrophy, myocardial oxygen requirements are 
higher than normal, yet perfusion pressure and, thus, 
oxygen supply may be decreased by a decrease in dia-
stolic pressure and an increased left ventricular end-
diastolic pressure [15].
Peripartum anesthetic considerations thus center on 
minimizing pain and, therefore, catecholamine-induced 
increases in SVR; avoiding bradycardia, which serves to 
increase time for regurgitant fl ow; and avoiding myocar-
dial depressants, which may exacerbate failure. The an-
esthetic concerns are similar to those for patients with 
mitral regurgitation, and epidural anesthesia for labor 
and delivery is desirable in order to prevent increases 
in peripheral vasoconstriction [1,6,20]. Invasive moni-
toring is a requirement in any patient with symptoms of 
congestive heart failure [1,15].
Valve replacement and anticoagulation
Pregnant women who have undergone mitral or aortic 
valve replacement may present with complications such 
as thromboembolism, valvular outfl ow obstruction, en-
docarditis, and hemolysis [32,33]. Anticoagulation with 
coumarin derivatives is usually necessary to prevent the 
thromboembolitic complications. In pregnancy, heparin 
is usually substituted for coumarin anticoagulants to 
avoid congenital anomalies in the fetus [34]. Anticoagu-
lation poses the threat of an epidural-spinal hematoma 
and is a contraindication to the use of regional anesthe-
sia. The use of low-molecular-weight heparin (enoxapa-
rin) has been associated with spinal epidural hematoma 
when regional anesthesia was used or attempted in 
Europe and, recently, in the United States [35]. This is 
probably due to its longer half-life by comparison with 
unfractionated heparin. It is therefore recommended 
that regional anesthesia not be administered unless the 
drug has been discontinued for at least 12–24 h, depend-
ing on the dosage. One alternative is to continue hepa-
rinization throughout labor and delivery and to use 
systemic analgesia for labor and general anesthesia for 
delivery. Another option with unfractionated heparin is 
to discontinue heparin therapy just prior to labor and 
delivery, normalize the coagulation parameters, use re-
gional anesthesia, and restart heparin 12 h later.
Summary
Valvular heart disease can affect anyone at any time, 
and pregnant women are no exceptions. Pregnancy rep-
resents a signifi cant physiological burden for women 
with underlying valvular heart disease [1]. The success-
ful management of pregnant women with valvular heart 
disease depends on the cooperative efforts of a multi-
disciplinary team of experts, including the obstetrician, 
the cardiologist, and the obstetric anesthesiologist 
among many others involved in the peripartum care of 
these patients. A comprehensive understanding of the 
physiology of pregnancy and the pathophysiology of 
underlying valvular heart defects is of primary impor-
tance in the obstetric and anesthetic management of this 
high-risk group of parturients [6]. Timely provision of 
labor analgesia and adequate peripartum monitoring of 
hemodynamic parameters is essential for the reduction 
of maternal morbidity and mortality.
References
 1. Kuczkowski KM (2004) Labor analgesia for the parturient with 
cardiac disease: what does an obstetrician need to know? Acta 
Obstet Gynaecol Scand 83:223–233
 2. Korsten HH, Van Zundert AA, Mooij PN (1989) Emergency 
aortic valve replacement in the twenty-fourth-week of pregnancy. 
Acta Anaesthesiol Belg 40:201–205
 3. Malhotra M, Sharma JB, Tripathii R (2004) Maternal and fetal 
outcome in valvular heart disease. Int J Gynaecol Obstet 84:
11–16
 4. Gomar C, Errando CL (2005) Neuroaxial anaesthesia in obstetri-
cal patients with cardiac disease. Curr Opin Anaesthesiol 18:507–
512
 5. Essop MR, Nkomo VT (2005) Rheumatic and nonrheumatic val-
vular heart disease: epidemiology, management, and prevention 
in Africa. Circulation 112:3584–3591
 6. Reisner LS, Kuczkowski KM (2003) Anesthetic considerations 
for complicated pregnancies. In: Creasy RK, Resnik R, Iams JD 
K.M. Kuczkowski and A. van Zundert: State-of-the-art anesthesia for pregnant women with heart disease 257
(eds) Maternal-Fetal medicine. Elsevier Science, Philadelphia, 
PA, pp 1243–1260
 7. Kuczkowski KM, Reisner LS, Lin D (2004) Anesthesia for cesar-
ean section. In: Chestnut DH (ed) Obstetric anesthesia: principles 
and practice. Elsevier Mosby, Philadelphia, PA, pp 421–446
 8. Clark SL (1991) Cardiac disease in pregnancy. Crit Care Obstet 
18:237–256
 9. Soeda M, Shiono M, Inoue T (2006) A successfully operated case 
of prosthetic valve thrombosis during planned pregnancy. Ann 
Thorac Cardiovasc Surg 12:66–70
10. Butchart EG, Gohlke-Barwolf C, Antunes MJ (2005) Recom-
mendations for the management of patients after heart valve sur-
gery. Eur Heart J 26:2463–2471
11. Elkayam U, Bitar F (2005) Valvular heart disease and pregnancy: 
part II: prosthetic valves. J Am Coll Cardiol 46:403–410
12. Elkayam U, Bitar F (2005) Valvular heart disease and pregnancy: 
part I: native valves. J Am Coll Cardiol 46:223–230
13. Kuczkowski KM (2006) The safety of anaesthetics in pregnant 
women. Expert Opin Drug Saf 5:251–264
14. Kuczkowski KM (2006) Nonobstetric surgery in the parturient: 
anesthetic considerations. J Clin Anesth 18:5–7
15. Mangano DT (2002) Anesthesia for the pregnant cardiac patient. 
In: Hughes SC, Levinson G, Rosen MA (eds) Shnider and Levin-
son’s anesthesia for obstetrics. Lippincott, Williams and Wilkins, 
Philadelphia, PA, pp 345–381
16. Kuczkowski KM, Chow I (2004) Peripartum anesthetic manage-
ment of the parturient with severe aortic stenosis: regional vs 
general anesthesia? Ann Fr Anesth Reanim 23:758–760
17. Kuczkowski KM, Reisner LS, Benumof LJ (2004) The diffi cult 
airway: risk, prophylaxis and management. In: Chestnut DH (ed) 
Obstetric anesthesia: principles and practice. Elsevier Mosby, 
Philadelphia, PA, pp 535–561
18. Reimold SC, Rutherford JD (2003) Clinical practice. Valvular 
heart disease in pregnancy. N Engl J Med 349:52–59
19. Bonow RO, Carabello BA, Kanu C (2006) American College of 
Cardiology/American Heart Association Task Force on Practice 
Guidelines; Society of Cardiovascular Anesthesiologists; Society 
for Cardiovascular Angiography and Interventions; Society of 
Thoracic Surgeons. ACC/AHA 2006 guidelines for the manage-
ment of patients with valvular heart disease: a report of the Amer-
ican College of Cardiology/American Heart Association Task 
Force on Practice Guidelines (writing committee to revise the 
1998 Guidelines for the Management of Patients With Valvular 
Heart Disease): developed in collaboration with the Society of 
Cardiovascular Anesthesiologists: endorsed by the Society for 
Cardiovascular Angiography and Interventions and the Society of 
Thoracic Surgeons. Circulation 114:84–231
20. Reisner LS (1998) The pregnant patient and the disorders of 
pregnancy. In: Benumof J (ed) Anesthesia and uncommon dis-
eases. WB Saunders, Philadelphia, PA, pp 459–464
21. Head CE, Thorne SA (2005) Congenital heart disease in preg-
nancy. Postgrad Med J 81:292–298
22. Carpenter AJ, Camacho M (2004) Valvular heart disease in 
women: the surgical perspective. J Thorac Cardiovasc Surg 127:
4–6
23. DeLaRosa J, Sharoni E, Guyton RA (2002) Pregnancy and val-
vular heart disease. Heart Surg Forum 6:7–9
24. Lim ST (2002) Rheumatic heart diseases in pregnancy. Ann Acad 
Med Singapore 31:340–348
25. Ray P, Murphy GJ, Shutt LE (2004) Recognition and manage-
ment of maternal cardiac disease in pregnancy. Br J Anaesth 
93:428–439
26. Abbas AE, Lester SJ, Connolly H (2005) Pregnancy and the 
cardiovascular system. Int J Cardiol 98:179–189
27. Izgi C, Cevik C, Ozkan M (2005) Reconsidering anticoagula-
tion issue of pregnant women with mitral stenosis. Am J Obstet 
Gynecol 193:501–504
28. Sivadasanpillai H, Srinivasan A, Sivasubramoniam S (2005) Long-
term outcome of patients undergoing balloon mitral valvotomy in 
pregnancy. Am J Cardiol 95:1504–1506
29. Freeman RV, Crittenden G, Otto C (2004) Acquired aortic 
stenosis. Expert Rev Cardiovasc Ther 2:107–116
30. Yap SC, Takkenberg JJ, Witsenburg M (2005) Aortic stenosis at 
young adult age. Expert Rev Cardiovasc Ther 3:1087–1098
31. Orme RM, Grange CS, Ainsworth QP, Grebenik CR (2004) 
General anaesthesia using remifentanil for caesarean section in 
parturients with critical aortic stenosis: a series of four cases. Int 
J Obstet Anesth 13:183–187
32. Pocock SB, Chen KT (2006) Inappropriate use of antibiotic pro-
phylaxis to prevent infective endocarditis in obstetric patients. 
Obstet Gynecol 108:280–285
33. De Santo LS, Romano G, Della Corte A (2005) Mitral mechanical 
replacement in young rheumatic women: analysis of long-term 
survival, valve-related complications, and pregnancy outcomes 
over a 3707-patient-year follow-up. J Thorac Cardiovasc Surg 
130:13–19
34. Kuczkowski KM, Fernández CL, Pérez PT (2006) Pasaje trans-
placentario de drogas, In: Aldrete JA, Paladino MA (eds). Far-
macología para anestesiólogos, intensivistas, emergentologos y 
medicina del dolor. Corpus, Buenos Aires, pp 629–647
35. Horlocker TT, Wedel DJ, Benzon H (2003) Regional anesthesia 
in the anticoagulated patient: defi ning the risks (the second ASRA 
Consensus Conference on Neuraxial Anesthesia and Anticoagu-
lation). Reg Anesth Pain Med 28:172–197
